1h
Hosted on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...
Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.
There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...
The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...
Dr Craig Koniver, a family physician in Charleston, South Carolina, said he currently has 200 patients using the same method ...
Rapid fat loss from GLP-1 medications like Ozempic can lead to 'Ozempic face', characterized by hollow cheeks and sagging ...
“The first thing they see is the loose skin on their abdomen," says R. Brannon Claytor, a Bryn Mawr, Pa.-based plastic ...
Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...
Medical experts have raised concerns over popular weight loss drugs like Ozempic and Mounjaro after emerging evidence found ...
17h
The Punch Newspapers on MSNRebel Wilson Weight Loss Transformation JourneyYou've probably seen the headlines about Rebel Wilson's incredible weight loss transformation. The actress, known for ...
Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results